×
An 8-Week, Open-Label Trial of Duloxetine for Comorbid Major Depressive Disorder and Chronic Headache PDF
$ 40.00
An 8-Week, Open-Label Trial of Duloxetine for Comorbid Major Depressive Disorder and Chronic Headache PDF quantity
$ 40.00
×
A Pharmacokinetic and Clinical Evaluation of Switching Patients With Bipolar I Disorder From Delayed-Release to Extended-Release Divalproex PDF
$ 40.00
A Pharmacokinetic and Clinical Evaluation of Switching Patients With Bipolar I Disorder From Delayed-Release to Extended-Release Divalproex PDF quantity
$ 40.00
×
Bereavement and the Diagnosis of Major Depressive Episode in the National Epidemiologic Survey on Alcohol and Related Conditions PDF
$ 40.00
Bereavement and the Diagnosis of Major Depressive Episode in the National Epidemiologic Survey on Alcohol and Related Conditions PDF quantity
$ 40.00
×
Is Baseline Medication Resistance Associated With Potential for Relapse After Successful Remission of a Depressive Episode With ECT? Data From the Consortium for Research on Electroconvulsive Therapy (CORE) PDF
$ 40.00
Is Baseline Medication Resistance Associated With Potential for Relapse After Successful Remission of a Depressive Episode With ECT? Data From the Consortium for Research on Electroconvulsive Therapy (CORE) PDF quantity
$ 40.00
×
A Double-Blind Randomized Controlled Trial of Doxazosin for Co-Occurring PTSD and Alcohol Use Disorder in Veterans PDF
$ 40.00
A Double-Blind Randomized Controlled Trial of Doxazosin for Co-Occurring PTSD and Alcohol Use Disorder in Veterans PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart